- Home
- APRE vs INTJ Comparison
APRE vs INTJ Comparison
Compare APRE & INTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- INTJ
- Stock Information
- Founded
- APRE 2006
- INTJ 2016
- Country
- APRE United States
- INTJ Hong Kong
- Employees
- APRE N/A
- INTJ N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- INTJ
- Sector
- APRE Health Care
- INTJ
- Exchange
- APRE Nasdaq
- INTJ NYSE
- Market Cap
- APRE 10.0M
- INTJ 11.2M
- IPO Year
- APRE 2019
- INTJ 2024
- Fundamental
- Price
- APRE $1.89
- INTJ $1.22
- Analyst Decision
- APRE Strong Buy
- INTJ
- Analyst Count
- APRE 2
- INTJ 0
- Target Price
- APRE $15.50
- INTJ N/A
- AVG Volume (30 Days)
- APRE 50.1K
- INTJ 238.2K
- Earning Date
- APRE 08-11-2025
- INTJ 08-01-2025
- Dividend Yield
- APRE N/A
- INTJ N/A
- EPS Growth
- APRE N/A
- INTJ N/A
- EPS
- APRE N/A
- INTJ N/A
- Revenue
- APRE $1,284,475.00
- INTJ $2,607,186.00
- Revenue This Year
- APRE N/A
- INTJ N/A
- Revenue Next Year
- APRE N/A
- INTJ N/A
- P/E Ratio
- APRE N/A
- INTJ N/A
- Revenue Growth
- APRE 33.27
- INTJ N/A
- 52 Week Low
- APRE $1.41
- INTJ $0.48
- 52 Week High
- APRE $5.01
- INTJ $1.70
- Technical
- Relative Strength Index (RSI)
- APRE 55.82
- INTJ N/A
- Support Level
- APRE $1.60
- INTJ N/A
- Resistance Level
- APRE $2.22
- INTJ N/A
- Average True Range (ATR)
- APRE 0.17
- INTJ 0.00
- MACD
- APRE 0.03
- INTJ 0.00
- Stochastic Oscillator
- APRE 46.77
- INTJ 0.00
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About INTJ INTELLIGENT GROUP LTD
Intelligent Group Ltd is a professional services provider in Hong Kong that principally engages in the provision of Financial PR services. The company provides a substantial number of holistic and comprehensive Financial PR services to its clients through its key operating entity in Hong Kong. It advises its clients on their communications and reputation management efforts. Its Financial PR services include creating multi-stakeholder communications programs, arranging press conferences and interviews, participating in the preparation of news releases and shareholders' meetings, monitoring news publications, identifying shareholders, targeting potential investors, organizing corporate events, and implementing crisis management policies and procedures.